Loading ...

Peter Sayre

Immune Tolerance Network

Assessment Group

psayre@immunetolerance.org

Work:

415-353-4423

Mobile:

415-353-4404

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN029ST

-

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

ITN030ST

-

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

ITN032AD

-

Promoting Tolerance to Peanut in High-Risk Children

ITN033AI

-

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

ITN034AI

-

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

ITN036ST

-

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

ITN040CT

-

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

ITN049AD

-

Persistence of Oral Tolerance to Peanut

ITN052AD

-

Peanut Protein Quantification Study for LEAP

ITN053AD

-

Peanut protein quantification study for LEAP-ON

ITN054ST

-

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

ITN068AD

-

GLA plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy

ITN069ST

-

Renal Allograft Tolerance Through Mixed Chimerism And Co-Stimulation Blockade With Belatacept

ITN507ST

-

Study of Tolerant Kidney Transplant Recipients

ITN524ST-CTOT-12

-

Associating Renal Transplantation With the ITN Signature of Tolerance

Bio:

Admin Links

Shortcuts

ITN Documents

Links